Algunas personas que padecen leucemia mieloide aguda (AML) tienen uno o más de los factores de riesgo conocidos (consulte la sección. Gracias a los avances en los tratamientos y los ensayos clínicos, las perspectivas para los niños con leucemia mieloide aguda son esperanzadoras. Tratamiento de la leucemia promielocítica aguda. .. acute promyelocytic leukemia (M3) developing into an M3 acute myelocytic leukemia without PML/ RARa.

Author: Galar Shagis
Country: India
Language: English (Spanish)
Genre: Photos
Published (Last): 26 April 2005
Pages: 457
PDF File Size: 6.82 Mb
ePub File Size: 4.14 Mb
ISBN: 210-7-11537-943-1
Downloads: 42857
Price: Free* [*Free Regsitration Required]
Uploader: Manos

High frequency of acute promyelocyitic leukemia in Mexican Mestizos. Treatment of acute promyelocytic leukemia: Kaplan EL, Meier P.

¿Qué causa la leucemia mieloide aguda?

Leuk Lymphoma ; High frequency of acute promyelocytic leukemia in Mexican mestizos. Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. There were no instances of the ATRA syndrome.

Ann Biol Clin ; Association between increased body mass index and a diagnosis of acute promyelocytic leukemia promielociticca patients with acute myeloid leukemia. From genetics to treatment.

Tratamiento de la leucemia promielocítica aguda: Experiencia de una sola institución

Nonparametric estimations from incomplete observations. Annu Rev Med ; The molecular remission was achieved after the administration of ATRA in five patients, whereas in the remaining eight, chemotherapy CT was required to finally achieve it.


Semin Hematol ; The roles of both consolidation therapy with CT including anthracyclines as well as the maintenance therapy with ATRA, mercaptopurine and methotrexate have been also well defined. Acta Haematol ; Principles, applications and problems.

¿Sabemos qué causa la leucemia mieloide aguda?

High frequency of acute promyelocytic leukemia among latinos with acute myeloid leukemia Letter. Vasco de Quiroga No. Blood ; 90 Suppl. Toxicity and survival in de novo patients. A single institution experience.

More on geographic hematology: Three patients received an autologous peripheral blood stem cell transplantation 4, 6, 9,19 after achieving the molecular remission, in two instances during the first CR and in one, during the second CR vide supra.

Acute promyelocytic leukemia as a paradigm for targeted therapy. Clin Lab Haematol ; The treatment employed differs from others in: Outpatient supportive therapy after induction to remission therapy in adult leuxemia myelogenous leukaemia AML is feasible: Report of the first Latin American consensus conference for flow cytometric immunophenotyping of leukemia.

Results from several randomized studies have evaluated various regimens of ATRA alone or in combination with CT to determine optimal induction therapy in patients with newly diagnosed APL.


Recibido el 4 de noviembre de J Am Stat Assoc ; Cellular immunophenotypes in 97 adults with acute leukemia. Eur J Haematol ; Blood ; 84 Suppl. Promyelocytic leukemia in Mexican mestizos.

Oral prednisone is used prophylactically, ATRA is given on an outpatient basis and adriamycin is used instead of other anthracyclines. Correspondence and reprint request: Aceptado el 6 de abril de Cytometry Communications in Clinical Cytometry ; Substantial progress has occurred in the treatment of APL because of improved understanding of the pathophysiology of the disease and identification of a molecular promielocitoca. Am J Hematol ; Fourteen patients leuce,ia followed for more than 30 days and therefore, prospectively accrued in this study; they were observed for periods ranging from 67 to 4, days median 1, In addition, we elected to deliver ATRA fully on an outpatient basis, thus diminishing hospitalization costs.

Flow cytometry lfucemia the clinical laboratory. Medicin Univ ; 1: Pathogenesis and management of acute promyelocytic leukemia.